# Corrigendum: Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

**Authors:** Francisca Sivera, Victoria Núñez-Monje, Cristina Campos-Fernández, Isabel Balaguer-Trull, Montserrat Robustillo-Villarino, Marta Aguilar-Zamora, Marta Garijo-Bufort, Juan Miguel López-Gómez, Carolina Peña-González, Isabel de la Morena, Diego Bedoya-Sanchís, Liliya Yankova-Komsalova, Arantxa Conesa-Mateos, Anna Martínez-Cristóbal, Francisco Javier Navarro-Blasco, José Miguel Senabre-Gallego, Juan José Alegre-Sancho

PMC · DOI: 10.3389/fmed.2024.1462054 · Frontiers in Medicine · 2024-09-10

## Full-text entities

- **Diseases:** axial spondyloarthritis (MESH:D000089183)
- **Chemicals:** secukinumab (MESH:C555450)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11421476/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11421476/full.md

---
Source: https://tomesphere.com/paper/PMC11421476